A detailed history of Mogy Joel R Investment Counsel Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mogy Joel R Investment Counsel Inc holds 19,160 shares of BMY stock, worth $1.13 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
19,160
Previous 20,160 4.96%
Holding current value
$1.13 Million
Previous $837,000 18.4%
% of portfolio
0.06%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$39.66 - $51.75 $39,660 - $51,750
-1,000 Reduced 4.96%
19,160 $991,000
Q2 2024

Jul 12, 2024

SELL
$40.25 - $52.99 $40 - $52
-1 Reduced -0.0%
20,160 $837,000
Q1 2024

Apr 30, 2024

SELL
$47.98 - $54.4 $35,937 - $40,745
-749 Reduced 3.58%
20,161 $1.09 Million
Q3 2023

Nov 01, 2023

SELL
$57.89 - $64.73 $578,900 - $647,300
-10,000 Reduced 32.35%
20,910 $1.21 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $19,113 - $21,222
-300 Reduced 0.96%
30,910 $1.98 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $65 - $74
1 Added 0.0%
31,210 $2.16 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $22,802 - $25,113
314 Added 1.02%
31,209 $2.4 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $1.49 Million - $1.74 Million
27,806 Added 900.16%
30,895 $1.93 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $1.49 Million - $1.74 Million
-27,806 Reduced 90.0%
3,089 $1.93 Million
Q2 2019

Aug 08, 2019

SELL
$44.62 - $49.34 $8,924 - $9,868
-200 Reduced 0.64%
30,895 $1.4 Million
Q1 2018

May 02, 2018

SELL
$59.92 - $68.98 $35,952 - $41,388
-600 Reduced 1.89%
31,095 $1.97 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $1.75 Million - $2.02 Million
31,695
31,695 $2.02 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mogy Joel R Investment Counsel Inc Portfolio

Follow Mogy Joel R Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mogy Joel R Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mogy Joel R Investment Counsel Inc with notifications on news.